Review
Jul 2026
Anti-PD-1 single-chain variable fragments in cancer immunotherapy: from molecular engineering to clinical translation
Taken together, anti-PD-1 scFvs represent a modular platform for localized checkpoint inhibition and potentially improved cost-effectiveness compared with systemic antibodies.
Zahraa A. Alkhafaje, H. Malathi, A. Dash et al.
· Cancer Chemotherapy and Phar... · 0 citations